Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ABBV-8736 / AbbVie
NCT05901883: First-in-human, Single Ascending Dose Study of CEL383 in Healthy Adult Subjects	Completed	1	48	US	CEL383, Placebo	Celsius Therapeutics, Inc.	Healthy	01/24	01/24